UBA1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, UBA1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated UBA1 data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher UBA1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated UBA1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and GBM show a favorable association.

CCRCC, COAD, and HNSC are the cancer types where UBA1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
CCRCCDFSMedianIII,IV0.9850.144.0089view →
COADDFSMedianIV0.4320.944.0126view →
HNSCOSMedianAll0.9360.993.0156view →
GBMDFSMedianAll0.4860.258.0166view →
PDACDFSTertileIV0.2030.752.0243view →
UCECOSMedianAll0.9120.985.0332view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

UBA1–CCRCC (DFS)

Kaplan–Meier survival curve for UBA1 mass-spec protein-high vs -low samples in CCRCC.

Open the CCRCC breakdown →

Exploration